For HDAC2, we found a positive involvement of MHCs with a higher fold enrichment than for CIITA and B2M, suggesting that its (de)regulation in CRC is tightly involved in immune regulation and immune-related genes (Table 5). The gene discussed is HDAC2; the disease is colorectal carcinoma.